Stay updated with breaking news from 29089q10. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Emergent BioSolutions (NYSE:EBS – Get Free Report) posted its quarterly earnings results on Wednesday. The biopharmaceutical company reported $0.59 earnings per share for the quarter, beating the consensus estimate of ($3.65) by $4.24, Zacks reports. Emergent BioSolutions had a negative net margin of 47.68% and a negative return on equity of 17.91%. The firm had […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the recipient of unusually large options trading activity on Wednesday. Traders purchased 3,153 put options on the stock. This is an increase of 344% compared to the typical daily volume of 710 put options. Emergent BioSolutions Stock Performance Shares of NYSE:EBS traded up $0.03 on Wednesday, […]
Emergent BioSolutions Inc. (NYSE:EBS – Get Free Report) was the target of a significant drop in short interest in March. As of March 15th, there was short interest totalling 4,910,000 shares, a drop of 20.8% from the February 29th total of 6,200,000 shares. Based on an average trading volume of 3,000,000 shares, the short-interest ratio […]
Benchmark upgraded shares of Emergent BioSolutions (NYSE:EBS – Free Report) from a hold rating to a buy rating in a research report sent to investors on Thursday morning, MarketBeat reports. They currently have $5.00 price objective on the biopharmaceutical company’s stock. A number of other analysts have also issued reports on the stock. JPMorgan Chase […]
Emergent BioSolutions (NYSE:EBS – Get Free Report) is scheduled to post its quarterly earnings results on Monday, February 26th. Emergent BioSolutions (NYSE:EBS – Get Free Report) last posted its quarterly earnings data on Monday, December 11th. The biopharmaceutical company reported ($1.44) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.12) by […]